CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity.
Patients with early stage, radial growth phase (RGP) melanoma have a 97% survival rate; however, when the melanoma progresses to the invasive vertical growth phase (VGP), survival rates decrease to 15%. The targets of many clinical trials are the known genetic and molecular mechanisms involved in me...
Main Authors: | Molly H Jenkins, Constance E Brinckerhoff, David W Mullins |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4370421?pdf=render |
Similar Items
-
Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem Cells
by: Robert C. Fisher, et al.
Published: (2019-03-01) -
LINC00888 promoted tumorigenicity of melanoma via miR-126/CRK signaling axis
by: Lu W, et al.
Published: (2018-07-01) -
CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5
by: Mushtaq A. Nengroo, et al.
Published: (2021-05-01) -
Primary thin nodular melanoma: An early tumorigenic vertical growth phase melanoma
by: Luca Roncati, et al.
Published: (2020-01-01) -
IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer.
by: Miao-Fen Chen, et al.
Published: (2013-01-01)